16th Annual Cardiovascular Update Conference
February 6th and 7th from 8:00 am - 5:00 pm
For details visit: Registration Page

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Twenty-Five Years Later: Remembering Sept. 11
    Today marks 25 years since Sept. 11, 2001 – a day forever etched into our collective memory. For those of us who lived through that morning, it can seem both a lifetime ago and only yesterday.
  • ACC, STS and SCAI Issue Joint Statement on TAVR National Coverage Determination
    The American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography & Interventions (SCAI) released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination finalized by the Centers for Medicare and Medicaid Services (CMS).
  • Look AHEAD: IL-6, Not hs-CRP, Identifies Risk of HF in Patients With T2D, Overweight/Obesity
    The inflammatory biomarker interleukin (IL)-6 identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity, particularly among those with no history of cardiovascular disease, according to results of a Look AHEAD ancillary study published Sept. 3 in JACC: Heart Failure.
  • GBD Study 2023: Myocarditis Burden Rising Despite Decline in DALYs, Mortality Rates
    Despite declines in disability-adjusted life years (DALYs) and mortality rates from myocarditis globally from 1990 to 2023, its incidence and prevalence remained stable, suggesting improvements in disease outcomes over time, according to a study using data from the GBD (Global Burden of Disease, Injuries, and Risk Factors Study) 2023 and published Sept. 2 in JACC.
  • Novel LA Staging Framework Stratifies NOAF Risk in HCM
    A novel left atrium (LA) staging framework proposed by Jaehyun Lim, MD, PhD, et al., was independently associated with a significant, stepwise increase in risk of new-onset atrial fibrillation (NOAF) in patients with hypertrophic cardiomyopathy (HCM), providing incremental predictive value beyond established atrial fibrillation (AFib) risk models, and may help tailor AFib surveillance strategies for […]